Down Syndrome Clinical Trial
Official title:
Using Anthropometric Measurements to Predict Orthotic Influence on Gait Parameters in Children With Down Syndrome
On average, Down syndrome (DS) occurs once in every 700 live births and results in life-long
disability and increased risk for comorbidities.1 Individuals with DS are also susceptible
to secondary physical impairments and limitations as a result of complications associated
with joint hypermobility, hypotonicity, and increased ligamentous laxity. Secondary
impairments such as pes planus (flat feet), weakened muscles, bony abnormalities and
arthritis may lead to painful joints and feet. Additionally, children with DS often manifest
deviations in gait as a result of physical limitations imposed by orthopedic and muscular
deficiencies that may lead to decreased postural stability. These secondary losses in
function, which exacerbate disabilities, may be preventable with the use of appropriate
early interventions aimed at correcting abnormal joint alignment. Research exploring
effective physical therapy interventions for adults and children with DS is currently very
limited. However, the use of orthotic devices to support lax ligaments and hypotonic
muscles, which are common manifestations of DS, is one accepted method of intervention for
children within this population. Orthoses are variable in structure and the degree of
support provided to the foot and ankle also differ between foot orthoses (FOs) and
supramalleolar orthoses (SMOs). Previous studies have supported the effectiveness of
orthoses on improving ankle and foot alignment, as well as gait parameters. However,
disagreement currently exists concerning which type of orthotic device is most beneficial
for the population of children with DS. Children with DS express variable degrees of joint
laxity and hypotonicity, as well as differences in the severity of specific alignment
abnormalities such as excessive pronation or calcaneal eversion.6 Current literature is
insufficient for explaining differences in the benefits provided by FOs and SMOs and the
specific indications for their use in children with DS is unclear.
Study Aims This study will demonstrate the differences in structural outcomes provided by
FOs and SMOs and develop specific criterion for matching individuals of differing orthopedic
impairments with the most beneficial orthotic device.
The purpose of this study is to demonstrate the differences in functional outcomes provided
by supramalleolar orthoses and foot orthoses, as well as develop specific criterion for
matching individuals with Down syndrome (DS) of differing orthopedic impairments with the
most beneficial orthotic device.
Participants must be able to walk independently or with an assistive device, such as a
walker, for 50 feet at one time, and have at least six months of walking experience.
Participants must also be able to follow simple verbal instructions. Both males and females
will be included in this study, and children of any race may participate as long as they
meet the inclusion criteria and are between three and ten years of age at the time of data
collection. Exclusion criteria include a history of uncorrected visual and inner ear
impairments, and lower extremity orthopedic surgical corrections.
There are no costs associated with participation in this study, and subjects will not be
paid for their participation.
Participants in this study will be fitted for the appropriate size orthoses either by
physical therapists in the participants' school district, or by one of the researchers prior
to data collection. The correct fitting orthotic will be sized using the sizing guides
provided by Cascade. These are footplates of various sizes that provide the length of the
child's foot in inches and the orthosis width that will fit the child. Measurements of
height, weight, leg length, medial longitudinal arch height, tibial torsion, and calcaneal
eversion will be taken for each subject. Weight will be measured in kilograms using a scale,
while height, leg length, and medial longitudinal arch height will be measured using a
metric tape measure. Tibial torsion will be measured with the participant lying in prone (on
their stomach) on the plinth with one knee flexed to 90 degrees. The angle of tibial torsion
is formed by a line perpendicular to the line between the medial and lateral malleoli of the
ankle, and a line parallel to the femur. This angle will be measured using a goniometer,
which is an instrument used to measure joint angles and range of motion, and this angle will
be measured once on each side. Finally, while standing, calcaneal eversion will be measured
by determining the angle between neutral calcaneal alignment and resting stance. Neutral
calcaneal alignment is found by palpating the position of the talus, so that the talus bone
is felt equally on both sides of the foot. Once neutral alignment has been determined a line
will be drawn with washable marker between the posterior talus and midline of the calf. The
participant will then be asked to stand in their normal position and a goniometer will be
used to measure the angle between the neutral alignment and the resting alignment of the
ankle.
In addition to these measurements, a hypermobility screen will be performed in which
mobility of fingers, wrists, elbows, knees, and the spine will be scored. The screen is
scored using a point system in which one point is given for the ability to perform each of
the tasks in the screen. These tasks include the ability to actively extend the little
fingers 90 degrees at the metacarpophalangeal joints, passively touch the thumbs to the
volar surface of the forearms, extend the wrists more than 90 degrees, extend elbows and
knees more than 10 degrees, and the ability to bend the spine to reach the floor with palms
flat on the ground. Gait of each participant will be assessed in conditions of shoes only,
with foot orthoses, and with supramalleolar orthoses. This order will be determined by
selecting a condition at random from a hat, such that the first condition chosen will be
performed and assessed first.
Gait parameters including step length, step width, walking speed, percentage of time spent
in single leg support, and variability in gait will be measured using a GAITRite mat. The
GAITRite measurement system includes an electronic walkway which contains sensor pads, and
is similar to a roll-out carpet. The GAITRite mat is then linked to a computer, which
collects information about gait as the participant walks across the mat. The GAITRite mat,
which is 20 feet long, will be set-up as one segment of a circular track so that total
walking distance of the loop will be 50 feet. Participants will be given an accommodation
period of ten minutes for both types of orthoses prior to gait assessment in which they will
be instructed to walk around the room and over the GAITRite mat in order to get comfortable
wearing the orthoses and walking along the track. Once the accommodation period is complete
for one orthosis, participants will walk around the track three times. This procedure of
accommodation and data collection will be repeated for each condition. Participants will be
given verbal encouragement by the researchers as they walk the track as a means of
motivation. Rest periods will be given to participants when requested, or when behavioral
cues displaying discomfort, pain, or frustration occur. Data collection will be stopped
altogether at the participant's request or if behavioral cues of discomfort persist. Trials
involving both supramalleolar and foot orthoses are hypothesized to increase step length,
walking speed, and time spent in single leg support from control trials in the shoes only
condition. Both orthoses are also expected to decrease step width, and variability in gait
parameters. Supramalleolar orthoses, which provide above-ankle support, are expected to
improve gait parameters to a greater magnitude than foot orthoses for participants who score
higher on the hypermobility screen and have greater tibial torsion and ankle eversion than
their cohorts. Conversely, foot orthoses are expected to provide greater improvement in gait
parameters than supramalleolar orthoses for participants who score lower on the
hypermobility screen and have less tibial torsion and ankle eversion than their cohorts due
to the need for less external foot and ankle support. An increase in step length, walking
speed, time spent in single leg support, and a decrease in step width and variability in
gait will indicate a positive result of orthoses use.
Students of physical therapy from the University of Puget Sound Physical Therapy Program
will perform all measurements, with the exception of orthotic size in some cases. One
researcher will perform all anthropometric measurements and the hypermobility screen on the
participants. A second researcher will operate the GAITRite mat, while the third researcher
will guide and instruct the participants along the GAITRite mat course.
;
Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04854122 -
Blood Flow Regulation in Individuals With Down Syndrome - Training Study
|
N/A | |
Completed |
NCT04020302 -
Self-Monitoring Shopping Intervention
|
N/A | |
Recruiting |
NCT01950624 -
DS-Connect {TM}: The Down Syndrome Registry
|
||
Completed |
NCT04751136 -
the Effect of Cerebrolysin on Physical and Mental Functions of Down Syndrome
|
Phase 2 | |
Completed |
NCT04767412 -
Inspiratory Muscle Training and Physical Fitness in Children With Down Syndrome Randomized Control Trial
|
N/A | |
Completed |
NCT04536506 -
Bobath and Vojta Therapy for DS
|
N/A | |
Not yet recruiting |
NCT04037579 -
Protocol for a Non-randomized Survey in Down Syndrome People Who Practice Sports. Self and Observers´ Perception.
|
||
Completed |
NCT02882698 -
Performance Analysis in Down Syndrome on Mobile Phone
|
N/A | |
Completed |
NCT01791725 -
A 4-Week Safety Study of Oral ELND005 in Young Adults With Down Syndrome Without Dementia
|
Phase 2 | |
Unknown status |
NCT01975545 -
Fluor Varnish With Silver Nanoparticles for Dental Remineralization in Patients With Trisomy 21
|
Phase 2 | |
Completed |
NCT01808508 -
Obstructive Sleep Apnea and Neurocognitive and Cardiovascular Function in Children With Down Syndrome
|
N/A | |
Terminated |
NCT00754013 -
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 6 To 10
|
Phase 3 | |
Terminated |
NCT00754052 -
Evaluating The Efficacy And Safety Of Donepezil Hydrochloride (Aricept) In The Treatment Of The Cognitive Dysfunction Exhibited By Children With Down Syndrome, Aged 11 To 17
|
Phase 3 | |
Completed |
NCT01313325 -
Hippotherapy to Improve the Balance of Children With Movement Disorders
|
N/A | |
Completed |
NCT01256112 -
Parent Supported Weight Reduction in Down Syndrome
|
N/A | |
Completed |
NCT01594346 -
Multicenter Vitamin E Trial in Aging Persons With Down Syndrome
|
Phase 3 | |
Completed |
NCT05343468 -
Life Skills Improved in Children With Down Syndrome After Using Assistive Technology
|
N/A | |
Suspended |
NCT05755464 -
Evaluation of Patients With Down Syndrome Compliance to Dental Therapy
|
||
Recruiting |
NCT04022460 -
Using Personal Mobile Technology to Identify Obstructive Sleep Apnea in Children With Down Syndrome (UPLOAD)
|
||
Completed |
NCT04818437 -
Effect of Core Stability Exercises and Balance Training in Postural Control Among Down Syndrome
|
N/A |